openPR Logo
Press release

Weitz & Luxenberg Airs Ads on Mesothelioma featuring Daniel J. Travanti

09-12-2006 12:14 PM CET | Politics, Law & Society

Press release from: Weitz & Luxenberg

Weitz & Luxenberg Airs Ads on Mesothelioma featuring Daniel J.

September 11, 2006, New York, NY — To highlight its effectiveness in fighting for those harmed by mesothelioma and other asbestos-related diseases, nationally-recognized mass torts and personal injury law firm Weitz & Luxenberg, P.C. is now airing two :30 commercials on the asbestos-related cancer featuring acclaimed actor Daniel J. Travanti of “Hill Street Blues” television fame.

The firm is known for spearheading asbestos cases, among others, winning a historic consolidated trial in 1991 involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s. Weitz & Luxenberg had 36 clients in that case and won $75 million. Another case yielded a $64.65 million award for four asbestos plaintiffs in 1996 (NY, docket # 10893/95), and, in 2002, the firm won a $53 million verdict in New York for a brake mechanic stricken by mesothelioma (docket No. 12658-00). The firm has recovered hundreds of millions more for its clients, many of whom formed the backbone of the victorious Allied war effort in the World War II.

Given the seriousness of the subject matter, careful consideration was given to choosing who would appear in the commercials, said managing partner Arthur M. Luxenberg. “We were very selective in choosing our spokesperson,” Luxenberg explained. “We were looking for someone who could speak to our client base and also project the stature of our firm. Daniel J. Travanti was ideal because he was someone widely known and who could also embody the kind of authority and gravitas that this issue demands.”

The hard-hitting spots, set in a courtroom, highlight the firm’s success and dedication to achieving impressive financial results for its clients. The ads seek to alert those who have been harmed by asbestos that though they may have been exposed to the carcinogen decades ago, they may still be eligible to seek legal compensation.

Mesothelioma is an asbestos-related cancer of the lining of the lung or the lining of the abdominal cavity. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles. Workers toiled innocently, perilously unaware that they were dealing with a deadly substance. Mesothelioma ruined their health, destroying their lives and shattering families. Weitz & Luxenberg represents numerous individuals who have serious injuries related to asbestos. These injuries include mesothelioma, lung cancer, asbestosis (a noncancerous, chronic lung ailment), and other cancers, such as those of the larynx and kidney.

People who have been injured by asbestos can contact Weitz & Luxenberg. Interested parties should call the Client Relations department at 1 (800) 476-6070 or via e-mail by writing to

Dave Kufeld
Client Relations
Weitz & Luxenberg
120 Wall Street
New York, NY 10038

About Weitz & Luxenberg:
Weitz & Luxenberg, founded in 1986, is one of the leading plaintiffs, mass torts, product liability, and personal injury litigation law firms in America. The firm has played leading roles in national and local litigations involving asbestos, DES, silicone breast implants, medical malpractice, and general negligence, among others. A forerunner in the legal fight against environmental polluters, Weitz & Luxenberg has worked with clients harmed by MTBE and mercury, among other toxins. The firm has won numerous cases involving dangerous pharmaceuticals, including Vioxx, achieving a $13.5 million verdict against Merck & Co. (docket No. ATLL129605). It also recently filed a case related to the harmful acne medicine, Accutane, manufactured by Hoffman-La Roche Inc. (State Supreme Court of New Jersey, May 2, 2006, Mass Tort general docket No. 271). The firm’s other active pharmaceutical litigations include actions against the manufacturers of Bextra, Celebrex, Ortho Evra and Seroquel.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Weitz & Luxenberg Airs Ads on Mesothelioma featuring Daniel J. Travanti here

News-ID: 11167 • Views:

More Releases from Weitz & Luxenberg

Weitz & Luxenberg Cited for Top NYS 2014 Product Liability Cases by New York Law …
Weitz & Luxenberg, P.C. has been recognized by the New York Law Journal for winning the top three product liability verdicts in New York State in 2014. “The lawyers and law firms who are ranked in this special section represent the best of the best in 2014,” New York Law Journal associate publisher Farrell McManus wrote in the Journal’s “Top Verdicts New York 2014.” He continued, “Their zealous advocacy on
Mesothelioma Treatment Tomudex Receives International Support
Mesothelioma Treatment Tomudex Receives International Support
Mesothelioma treatment Tomudex, made by a global pharmaceutical company, is receiving approval from a panel of international experts. Tomudex falls in the group of anti-cancer drugs known as antineoplastics. It prevents cell growth. By doing so, it leads to the elimination of tumors. In a study examining people diagnosed with pleural mesothelioma, the use of Tomudex in conjunction with Platinol resulted in improved response rates of 23.6% as opposed to
New Mesothelioma Treatment Technique Developed
New Mesothelioma Treatment Technique Developed
Extrapleural pneumonectomy, a surgical procedure that removes mesothelioma cancer from the lining of the lung, has been reported to be an effective new mesothelioma treatment technique. The technique was developed by Dr. Sugarbaker, the co-leader of the Brigham Biomedical Research Institute's Cancer Research Center, Chief of the Institute's Division of Thoracic Surgery and a Professor of Oncologic Surgery at Harvard Medical School. The surgical technique was applied on a mesothelioma patient
Mesothelioma Cancer: Possible Treatment Option
Mesothelioma Cancer: Possible Treatment Option
An experiment carried out in Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and the Medical University Vienna has tested the effectiveness of a genetically modified virus to treat mesothelioma in animals. The virus is known as Newcastle Disease Virus (NDV). Animals with mesothelioma administered with multiple doses of NDV responded better than those that received a single dose. The use of a genetically engineered virus to disrupt the function

All 5 Releases

More Releases for Daniel

Daniel Ricciardo becomes EightCap Official Ambassador
Australian F1® driver Daniel Ricciardo has joined forces with Forex & CFD Broker EightCap. Daniel has joined one of Australia’s fastest growing online trading companies as the official brand ambassador. “Getting to know the team at EightCap and their business made the decision a really comfortable one for me. EightCap is ambitious and just as passionate about the financial markets as I am about my career.” “Striving to be the
Atlanta, GA — Daniel J. Huff has become a Fellow of the American College of Lawyers, one of the premier legal associations in North America. The induction ceremony at which Dan became a Fellow took place recently before an audience of 700 persons during the recent Induction Ceremony at the 2018 Spring Meeting of the College in Phoenix, Arizona. The meeting had a total attendance of 850. Founded in 1950, the College
Daniel Bacon's Debut of Historical Novel, Frisco
SUNDAY- APRIL 3rd: The San Francisco Maritime Park Association is proud to present Daniel Bacon’s historical novel “Frisco” – a critically acclaimed production chronicling the San Francisco waterfront during the 1930’s. A portrait of San Francisco during the Great Depression, Frisco tells the story of Nick Benson and Clarisa McMahon, whose relationship is torn apart when financial hardships force them to take separate paths. During a longshoremen strike, they
Jackson Walker Welcomes Daniel Nossa
Daniel Nossa joins the Energy practice and the Derivatives group in the Houston office at Jackson Walker. Mr. Nossa represents issuers, underwriters, and derivative counterparties on an array of derivative and structured finance products. He provides regulatory advice to derivative dealers and end users in the energy industry. Mr. Nossa advises numerous private and public companies in negotiating the transaction and credit support documentation related to credit, commodity, equity, and
Team Daniel Foundation Debuts Revamped Magazine
Fayetteville, NC (November 23, 2010)—Team Daniel Foundation, an organization dedicated to supporting North Carolinians with developmental disabilities, has rejuvenated its quarterly magazine, EMPOWERED.The only publication in the state written specifically for the developmental disabilities community, EMPOWERED tailors its content to inform, educate and be a resource for families and individuals with developmental disabilities. The new EMPOWERED magazine is designed with a more functional and appealing layout, including new sections and powerful
Daniel Imperato on Normalizing Relations with Cuba
Washington DC (i1Connect News) – Daniel Imperato revisited a campaign promise today, to open communications and improve relations with Cuba. As the leading Independent candidate for President, Imperato – who has extensive world business and strategic experience – repeated his 2005 prediction that if the United States didn't take action with Cuba, someone else will. Back in June of 2007, Imperato called for an immediate meeting with Fidel Castro, once